Literature DB >> 11522823

Transcription activation by targeted recruitment of the RNA polymerase II CTD phosphatase FCP1.

P Licciardo1, L Ruggiero, L Lania, B Majello.   

Abstract

Human FCP1 in association with RNAP II reconstitutes a highly specific CTD phosphatase activity and is required for recycling RNA polymerase II (RNAP II) in vitro. Here we demonstrate that targeted recruitment of FCP1 to promoter templates, through fusion to a DNA-binding domain, stimulates transcription. We demonstrate that a short region at the C-terminus of the FCP1 protein is required and sufficient for activation, indicating that neither the N-terminal phosphatase domain nor the BRCT domains are required for transcription activity of DNA-bound FCP1. In addition, we demonstrate that the C-terminus region of FCP1 suffices for efficient binding in vivo to the RAP74 subunit of TFIIF and is also required for the exclusive nuclear localization of the protein. These findings suggest a role for FCP1 as a positive regulator of RNAP II transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522823      PMCID: PMC55871          DOI: 10.1093/nar/29.17.3539

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   19.160


  41 in total

1.  Inhibition of Tat transactivation by the RNA polymerase II CTD-phosphatase FCP1.

Authors:  P Licciardo; G Napolitano; B Majello; L Lania
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

Review 2.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 3.  Control of elongation by RNA polymerase II.

Authors:  J W Conaway; A Shilatifard; A Dvir; R C Conaway
Journal:  Trends Biochem Sci       Date:  2000-08       Impact factor: 13.807

4.  Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription.

Authors:  P Komarnitsky; E J Cho; S Buratowski
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

5.  Artificial recruitment of TFIID, but not RNA polymerase II holoenzyme, activates transcription in mammalian cells.

Authors:  D R Dorris; K Struhl
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO.

Authors:  J Archambault; G Pan; G K Dahmus; M Cartier; N Marshall; S Zhang; M E Dahmus; J Greenblatt
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

7.  FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.

Authors:  T Wada; G Orphanides; J Hasegawa; D K Kim; D Shima; Y Yamaguchi; A Fukuda; K Hisatake; S Oh; D Reinberg; H Handa
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

8.  A motif shared by TFIIF and TFIIB mediates their interaction with the RNA polymerase II carboxy-terminal domain phosphatase Fcp1p in Saccharomyces cerevisiae.

Authors:  M S Kobor; L D Simon; J Omichinski; G Zhong; J Archambault; J Greenblatt
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  A functional comparison of BRCA1 C-terminal domains in transcription activation and chromatin remodeling.

Authors:  T Miyake; Y F Hu; D S Yu; R Li
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

10.  The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity.

Authors:  G Napolitano; P Licciardo; P Gallo; B Majello; A Giordano; L Lania
Journal:  AIDS       Date:  1999-08-20       Impact factor: 4.177

View more
  7 in total

1.  The C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylation.

Authors:  Erika M Friedl; William S Lane; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

2.  The FCP1 phosphatase interacts with RNA polymerase II and with MEP50 a component of the methylosome complex involved in the assembly of snRNP.

Authors:  Paolo Licciardo; Stefano Amente; Luca Ruggiero; Maria Monti; Piero Pucci; Luigi Lania; Barbara Majello
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

3.  Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach.

Authors:  Chao-Jun Hu; Jian-Bo Pan; Guang Song; Xiao-Ting Wen; Zi-Yan Wu; Si Chen; Wen-Xiu Mo; Feng-Chun Zhang; Jiang Qian; Heng Zhu; Yong-Zhe Li
Journal:  Mol Cell Proteomics       Date:  2016-10-24       Impact factor: 5.911

4.  Expanding the functional repertoire of CTD kinase I and RNA polymerase II: novel phosphoCTD-associating proteins in the yeast proteome.

Authors:  Hemali P Phatnani; Janice C Jones; Arno L Greenleaf
Journal:  Biochemistry       Date:  2004-12-21       Impact factor: 3.162

5.  NMR structure of a complex containing the TFIIF subunit RAP74 and the RNA polymerase II carboxyl-terminal domain phosphatase FCP1.

Authors:  Bao D Nguyen; Karen L Abbott; Krzysztof Potempa; Michael S Kobor; Jacques Archambault; Jack Greenblatt; Pascale Legault; James G Omichinski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

6.  Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro.

Authors:  Runbo Zhong; Xiaoxiao Ge; Tianqing Chu; Jiajun Teng; Bo Yan; Jun Pei; Liyan Jiang; Hua Zhong; Baohui Han
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-21       Impact factor: 4.553

7.  CDK9/cyclin complexes modulate endoderm induction by direct interaction with Mix.3/mixer.

Authors:  Haiqing Zhu; Joanne R Doherty; Emin Kuliyev; Paul E Mead
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.